Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Labetalol Versus Phentolamine for the Management of Severe Preeclampsia , Randomized Controlled Clinical Trial

NCT06385600 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06385600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06385600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Labetalol Versus Phentolamine for the Management of Severe Preeclampsia , Randomized Controlled Clinical Trial
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
May 20, 2024
Completion date
March 20, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe pre-eclampsia